(groupsstakeholder,2.970414465569701)
(cases,2.970414465569701)
(presentwe,2.970414465569701)
(consensus,2.970414465569701)
(discharges,2.970414465569701)
(identifiedclinical,2.970414465569701)
(phase,2.970414465569701)
(aedsstudy,2.970414465569701)
(lesions,2.970414465569701)
(paper,2.970414465569701)
(rat,2.970414465569701)
(anterior,2.970414465569701)
(literaturearticles,2.970414465569701)
(rangetremor,2.970414465569701)
(partial-onset,2.970414465569701)
(surgery,2.970414465569701)
(inhibitors,2.970414465569701)
(pediatric,2.970414465569701)
(detection,2.970414465569701)
(adipose,2.970414465569701)
(newly,2.970414465569701)
(model,2.970414465569701)
(epilepsywe,2.970414465569701)
(epilepsy2,2.970414465569701)
(weeks,2.970414465569701)
(seizuresglatiramer,2.970414465569701)
(objective,2.970414465569701)
(meta-analysis,2.970414465569701)
(background,2.970414465569701)
(epilepsyginsenoside,2.970414465569701)
(usedseveral,2.970414465569701)
(delivery,2.970414465569701)
(compound,2.970414465569701)
(epilepsyattention,2.970414465569701)
(ptz-induced,2.970414465569701)
(statins,2.970414465569701)
(analysis,2.970414465569701)
(nucleus,2.970414465569701)
(taking,2.970414465569701)
(proposedstep,2.970414465569701)
(seizuresanimals,2.970414465569701)
(interest,2.970414465569701)
(gene,2.970414465569701)
(tumortwo,2.970414465569701)
(differentiation,2.970414465569701)
(coenzyme,2.970414465569701)
(management,2.970414465569701)
(rates,2.970414465569701)
(imbalance,2.970414465569701)
(prevalentlack,2.970414465569701)
(severity,2.970414465569701)
(epilepsydepression,2.970414465569701)
(clinical,2.970414465569701)
(syndrome,2.970414465569701)
(epilepsy16,2.970414465569701)
(epilepsysaikosaponin,2.970414465569701)
(treatment-refractory,2.970414465569701)
(immunological,2.970414465569701)
(epilepsystereotactic,2.970414465569701)
(autosomal,2.970414465569701)
(antiepileptic,2.970414465569701)
(common,2.970414465569701)
(seizuresour,2.970414465569701)
(mesial,2.970414465569701)
(different,2.970414465569701)
(application,2.970414465569701)
(conditionpyridoxine,2.970414465569701)
(childhoodrecords,2.970414465569701)
(highly,2.970414465569701)
(pyridoxine,2.970414465569701)
(antiepilepticspharmacoresistance,2.970414465569701)
(tissue,2.970414465569701)
(duplication,2.970414465569701)
(seizuresmethods,2.970414465569701)
(adjunctive,2.970414465569701)
(effects,2.970414465569701)
(persistence,2.970414465569701)
(seizuresadults,2.970414465569701)
(benign,2.970414465569701)
(therapeutic,2.970414465569701)
(goal,2.970414465569701)
(aim,2.970414465569701)
(self-limitedinterictal,2.970414465569701)
(patientsretention,2.970414465569701)
(effectshormone,2.970414465569701)
(infantile-onset,2.970414465569701)
(criteria,2.970414465569701)
(diagnosed,2.970414465569701)
(strada,2.970414465569701)
(stimulation,2.970414465569701)
(convexital,2.970414465569701)
(identifiedwe,2.970414465569701)
(age,2.970414465569701)
(cannabidiolpractitioner,2.970414465569701)
(surgical,2.970414465569701)
(safetyadult,2.970414465569701)
(acetate,2.970414465569701)
(radiosurgery,2.970414465569701)
(tumorsaim,2.970414465569701)
(reliably,2.970414465569701)
(mecp2,2.970414465569701)
(dogspharmacokinetics,2.970414465569701)
(treatmentidentification,2.970414465569701)
(novelwe,2.970414465569701)
(japanese,2.970414465569701)
(treatment-emergent,2.970414465569701)
(sudden,2.970414465569701)
(epileptiform,2.970414465569701)
(events,2.970414465569701)
(adverse,2.970414465569701)
(deficiency,2.970414465569701)
(solutionson-demand,2.970414465569701)
(drugsadministration,2.970414465569701)
(children,2.970414465569701)
(therapy,2.970414465569701)
(focal,2.970414465569701)
(purpose,2.970414465569701)
(vitamin,2.970414465569701)
(lobe,2.5649493574615367)
(brain,2.5649493574615367)
(mechanisms,2.5649493574615367)
(refractory,2.5649493574615367)
(drug,2.5649493574615367)
(seizures,2.5649493574615367)
(characterized,2.5649493574615367)
(temporal,2.5649493574615367)
(studies,2.5649493574615367)
(disorder,2.5649493574615367)
(treatment,2.0541237336955462)
(epilepsy,1.8718021769015913)
(patients,1.717651497074333)
